Skip to content
healthcare.dev

Zanaflex

NDC 73352-090, tizanidine hydrochloride, capsule, from Trifluent Pharma, LLC.

Product NDC
73352-090
Status
Listed
Labeler
Trifluent Pharma, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213798
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73352-090 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE8 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
73352-090-607335200906060 CAPSULE in 1 BOTTLE (73352-090-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9833a1b8-f530-4a06-bc77-7d11b6e94c65

Use it

Look up 73352-090 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73352-090 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73352-090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.